论文部分内容阅读
目的:探讨阿莫西林联合果胶铋治疗慢性萎缩性胃炎的临床效果。方法:于2015年6月到2016年6月间,在我院选择80例慢性萎缩性胃炎患者作为研究对象,将患者随机分为常规组(n=40)和阿莫西林组(n=40),给予常规组患者使用克拉霉素联合果胶铋治疗,对阿莫西林组患者使用阿莫西林联合果胶铋治疗,统计对比两组患者的治疗效果。结果:阿莫西林组患者治疗总有效率与常规组相比明显较高;阿莫西林组患者治疗后不良反应发生率与常规组相比明显较低,P<0.05。结论:阿莫西林联合果胶铋治疗慢性萎缩性胃炎的临床效果显著,可推广运用。
Objective: To investigate the clinical effect of amoxicillin combined with pectin bismuth in the treatment of chronic atrophic gastritis. Methods: From June 2015 to June 2016, 80 patients with chronic atrophic gastritis were selected as study subjects in our hospital. Patients were randomly divided into routine group (n = 40) and amoxicillin group (n = 40) ). Patients in the conventional group were treated with clarithromycin combined with pectin bismuth. Patients in the amoxicillin group were treated with amoxicillin combined with pectin bismuth, and the treatment effect was compared between the two groups. Results: The total effective rate of amoxicillin group was significantly higher than that of conventional group. The incidence of adverse reactions in amoxicillin group was significantly lower than that of conventional group (P <0.05). Conclusion: The clinical effect of amoxicillin combined with pectin bismuth in the treatment of chronic atrophic gastritis is significant and can be used widely.